Bennett Weintraub
Director · Apimeds Pharmaceuticals US, Inc.
Individual
- 2025
- Nov 13, 2025
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Bennett Weintraub's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Robert W. Duggan - $51.95M in SMMT purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $51.68M in ELVN purchases and sales in the last 12 months
- Daniel Patrick O'Day - $51.19M in GILD purchases and sales in the last 12 months
- HRTG GPE, LLC - $50.00M in KARD purchases and sales in the last 12 months
- Redmile Group, LLC - $49.64M in ADCT purchases and sales in the last 12 months
- Gary S. Guthart - $48.79M in ISRG purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Bennett Weintraub?
Bennett Weintraub is a corporate insider, tracked as Director of Apimeds Pharmaceuticals US, Inc. (APUS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Bennett Weintraub last file a Form 4?
The most recent primary Form 4 on record is dated 13 November 2025, one of 2 filings going back to 2025.